Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Bispebjerg Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00206973
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

Study on the relationship between the response of the airways to a bronchial provocation test with mannitol and the degree of airway inflammation in asthma patients.


Condition Intervention
Asthma
Procedure: mannitol test

Study Type: Observational
Study Design: Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics

Resource links provided by NLM:


Further study details as provided by Bispebjerg Hospital:

Estimated Enrollment: 40
Study Start Date: August 2005
Estimated Study Completion Date: September 2005
Detailed Description:

Study on the relationship between the response of the airways to a bronchial provocation test with mannitol and the degree of airway inflammation in asthma patients.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Steroid naive asthma.
  • Non-smoker

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00206973

Contacts
Contact: Celeste Porsbjerg, MD +45 35313069 porsbjerg@dadlnet.dk

Locations
Denmark
Respiratory Research Unit, Med. Clinic I, Bispebjerg Hospital, Bispebjerg Bakke 23 Recruiting
Copenhagen, NV, Denmark, 2400
Contact: Celeste Porsbjerg, MD    + 45 35313069    porsbjerg@dadlnet.dk   
Contact: Vibeke Backer, MD    35313069    backer@dadlnet.dk   
Principal Investigator: Celeste Porsbjerg, MD         
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Celeste porsbjerg, MD unaffilliated
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00206973     History of Changes
Other Study ID Numbers: 7654 - man 05
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: Denmark: Danish Medicines Agency

Additional relevant MeSH terms:
Inflammation
Pathologic Processes
Mannitol
Diuretics, Osmotic
Diuretics
Natriuretic Agents
Physiological Effects of Drugs
Pharmacologic Actions
Cardiovascular Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on September 22, 2014